Leora Horn

Vanderbilt University

Papers

2

Total Citations

58

H-Index

2

About

Leora Horn is a leading oncologist and researcher whose work has fundamentally shaped the understanding and treatment of lung cancer. Her primary focus is on thoracic malignancies, with a particular emphasis on non-small cell lung cancer (NSCLC) and the role of targeted therapies and immunotherapy. Dr. Horn’s major contributions include pivotal studies on the molecular drivers of lung cancer, such as ALK and EGFR mutations, and the clinical development of novel agents that have transformed patient outcomes. Her highly cited 2020 and 2014 papers, both titled "Cancer of the Lung," serve as comprehensive, authoritative reviews that have guided clinicians and researchers worldwide, accumulating over 58 citations collectively. Beyond these landmark reviews, Dr. Horn has been instrumental in advancing personalized medicine, leading clinical trials that established new standards of care for patients with advanced disease. Her work has earned her recognition as a key opinion leader, and she is widely respected for her dedication to bridging laboratory discoveries with bedside practice. For students and researchers, Dr. Horn exemplifies how rigorous clinical investigation can directly improve survival and quality of life for lung cancer patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
58
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Cancer of the Lung
42 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Vanderbilt University

Top Papers

  1. 1
    Cancer of the Lung
    42 citations · 2020
  2. 2
    Cancer of the Lung
    16 citations · 2014

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago